Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2

British Journal of Pharmacology

Volumn 122, Issue 5, 1997, Pages 793-795

  Sakkoula, Eleni ^a   Pipili Synetos, Eva ^a   Maragoudakis, M E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiogenesis; Chick chorioallantoic membrane (CAM); Interleukin 2 (IL 2); Nitric oxide (NO); Nitric oxide synthase (NOS)

Indexed keywords

ANGIOGENESIS INHIBITOR; INTERLEUKIN 2; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ALLANTOIS; ANIMALS; CELLS, CULTURED; CHICK EMBRYO; CHORION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-2; NEOVASCULARIZATION, PATHOLOGIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UMBILICAL VEINS;

EID: 0030727309     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701436     Document Type: Article

References (11)

1. CHIGO, D., ARESE, M., TODDE, R., VECCHI, A., SILVAGNO, F., COSTAMAGNA, C., DONG, Q-G., ALESSIO, M., HELLER, R., SOLDI, R., TRUCCO, F., GARBARINO, G., PESCARMONA, G., MANTOVANI, A., BUSSOLINI, F. & BOSIA, A. (1995). Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase. J. Exp. Med., 181, 9-19.
2. DENG, W., THIEL, B., TANNENBAUM, C.S., HAMILTON, T.A. & STUEHR, D.J. (1993). Synergistic cooperation between Tcell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. J. Immunol., 151, 322-329.
3. FOLKMAN, J. (1985). Tumour angiogenesis. Adv. Cancer Res., 43, 172-203.
4. HIBBS, J.B., WESTENFELDER, C., TAINTOR, R., VAVRIN, Z., KABLITZ, C., BRANOWSKI, R.L., WARD, H., MENLOVE, L., MCMURRY, M.P., KUSHNER, J.P. & SAMLOWSKI, W.E. (1992). Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest., 89, 867-877.
5. HICKS, C., COOLEY, M.A. & PENNY, R. (1991). Investigation of interleukin-2 receptors on human endothelial cells. Growth Factors, 5, 201-208.
6. MARAGOUDAKIS, M.E., HARALABOPOULOS, G.C., TSOPANOGLOU, N.E. & PIPILI-SYNETOS, E. (1995). Validation of collagenous protein synthesis as an index for angiogenesis with the use of morphological methods. Microvasc. Res., 50, 215-222.
7. MARAGOUDAKIS, M.E., SARMONIKA, M. & PANOUTSAKOPOULOU, M. (1988). Role of basement membrane biosynthesis as an index to angiogenesis. Tissue Cell, 20, 531-539.
8. PIPILI-SYNETOS, E., PAPAGEORGIOU, A., SAKKOULA, E., SOTIROPOULOU, G., FOTSIS, T., KARKIOULAKIS, G. & MARAGOUDAKIS, M.E. (1995). Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol., 116, 1829-1834.
9. PIPILI-SYNETOS, E., SAKKOULA, E., HARALABOPOULOS, G., ANDRIOPOULOU, P., PERISTERIS, P. & MARAGOUDAKIS, M.E. (1994). Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol., 111, 894-902.
10. WHITTINGTON, R. & FAULDS, D. (1993). Interleukin-2: A Review. Drugs, 46, 446-514.
11. YIM, C.-Y., MCGREGOR, J.R., KWON, O.D., BASTIAN, N.R., REES, M., MORI, M., HIBBS, J.B. & SAMLOWSKI, W.E. (1995). Nitric oxide synthesis contributes to IL-2-induced antitumour responses against intraperitoneal meth A tumour. J. Immunol., 155, 4382-4390.